Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Takeda explores the potential of ‘digital biomarkers’

Collaborates with Mindstrong Health on mental health research

Takeda

Takeda is exploring the potential of ‘digital biomarkers’ to help develop new mental health treatments, with a particular focus on schizophrenia and treatment-resistant depression.

The firm is collaborating with Mindstrong Health, whose digital phenotyping platform continuously measures brain function from passively collected smartphone data.

Emiliangelo Ratti, head of Takeda’s Neuroscience Therapeutic Area Unit, said: "Mental health disorders are complex, multifaceted conditions, and drug development in this area of unmet need is slow to progress.

"This partnership with Mindstrong Health exemplifies Takeda's motivation to engage in digital technologies to improve the clinical assessment of patients with mental health conditions who lack adequate treatment options."

Dr Paul Dagum, founder and CEO of Mindstrong Health, added: "Takeda shares our goal of using innovative technology to gain insights that will improve outcomes for people living with mental health conditions.

"We are pleased to partner with them to implement digital technology in the clinical development of novel assets and, hopefully, allow for faster delivery of meaningful therapies to patients."

The companies hope that by joining forces they will be able to develop novel therapeutic interventions by applying digital biomarkers to stratify mental health conditions and predict remission.

6th March 2018

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wave Healthcare Communications

Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...